Tower Research Capital LLC (Trc) Stoke Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,012 shares of STOK stock, worth $84,354. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,012
Previous 4,018 74.51%
Holding current value
$84,354
Previous $54,000 59.26%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$12.24 - $15.92 $36,646 - $47,664
2,994 Added 74.51%
7,012 $86,000
Q2 2024

Aug 13, 2024
BUY
$11.03 - $17.52 $14,967 - $23,774
1,357 Added 51.0%
4,018 $54,000
Q1 2024

May 15, 2024
SELL
$4.12 - $14.17 $9,797 - $33,696
-2,378 Reduced 47.19%
2,661 $35,000
Q4 2023

Feb 13, 2024
BUY
$3.37 - $5.4 $4,374 - $7,009
1,298 Added 34.7%
5,039 $26,000
Q3 2023

Nov 14, 2023
SELL
$3.78 - $11.99 $3,560 - $11,294
-942 Reduced 20.12%
3,741 $14,000
Q2 2023

Aug 14, 2023
BUY
$7.93 - $13.82 $3,092 - $5,389
390 Added 9.08%
4,683 $49,000
Q1 2023

May 09, 2023
SELL
$7.65 - $10.38 $231,030 - $313,476
-30,200 Reduced 87.55%
4,293 $36,000
Q4 2022

Feb 10, 2023
BUY
$7.07 - $15.69 $219,834 - $487,864
31,094 Added 914.8%
34,493 $319,000
Q3 2022

Nov 10, 2022
SELL
$12.56 - $22.53 $17,282 - $31,001
-1,376 Reduced 28.82%
3,399 $44,000
Q2 2022

Aug 15, 2022
SELL
$10.36 - $23.93 $44,392 - $102,540
-4,285 Reduced 47.3%
4,775 $63,000
Q1 2022

May 12, 2022
BUY
$17.19 - $26.1 $101,850 - $154,642
5,925 Added 189.0%
9,060 $190,000
Q4 2021

Feb 14, 2022
BUY
$18.11 - $30.72 $28,414 - $48,199
1,569 Added 100.19%
3,135 $75,000
Q3 2021

Nov 15, 2021
SELL
$23.65 - $34.44 $141,166 - $205,572
-5,969 Reduced 79.22%
1,566 $40,000
Q2 2021

Aug 16, 2021
BUY
$30.53 - $41.09 $182,630 - $245,800
5,982 Added 385.19%
7,535 $254,000
Q1 2021

May 17, 2021
SELL
$36.08 - $69.81 $16,091 - $31,135
-446 Reduced 22.31%
1,553 $60,000
Q4 2020

Feb 16, 2021
SELL
$33.62 - $61.93 $175,899 - $324,017
-5,232 Reduced 72.36%
1,999 $124,000
Q3 2020

Nov 16, 2020
BUY
$22.23 - $37.48 $56,175 - $94,711
2,527 Added 53.72%
7,231 $243,000
Q2 2020

Aug 13, 2020
BUY
$20.26 - $29.73 $95,303 - $139,849
4,704 New
4,704 $112,000

Others Institutions Holding STOK

# of Institutions
123
Shares Held
57.6M
Call Options Held
9.3K
Put Options Held
35.2K
View Full List

About Stoke Therapeutics, Inc.

STOK Quotes by TradingView
  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $474M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email